Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns. - Petit PR; Touret F; Driouich JS; Cochin M; Luciani L; Bernadin O; Laprie C; Piorkowski G; Fraisse L; Sjö P; Mowbray CE; Escudié F; et al. (Heliyon, 2024)